Methylprednisolone as an antiemetic drug
- 1 April 1985
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 14 (3) , 235-237
- https://doi.org/10.1007/bf00258123
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antiemetic Efficacy of High-Dose Dexamethasone in Induction Therapy in Acute Nonlymphocytic LeukemiaAnnals of Internal Medicine, 1984
- Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.Journal of Clinical Oncology, 1984
- Randomized open cross-over trial between Metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomitingEuropean Journal of Cancer and Clinical Oncology, 1984
- On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapyEuropean Journal of Cancer and Clinical Oncology, 1983
- High-dose dexamethasone for prevention of cis-platin-induced vomitingCancer Chemotherapy and Pharmacology, 1981
- Dexamethasone as an antiemetic in patients treated with cisplatin.1981
- Methylprednisolone as an AntiemeticNew England Journal of Medicine, 1981
- Methylprednisolone as an antiemetic during cancer chemotherapy—a pilot studyGynecologic Oncology, 1980